119 related articles for article (PubMed ID: 10234541)
1. Effect of the amphoteric properties of salbutamol on its release rate through a polypropylene control membrane.
Imboden R; Imanidis G
Eur J Pharm Biopharm; 1999 Mar; 47(2):161-7. PubMed ID: 10234541
[TBL] [Abstract][Full Text] [Related]
2. Utilizing vehicle imbibition by a microporous membrane and vehicle viscosity to control release rate of salbutamol.
Imanidis G; Imboden R
Eur J Pharm Biopharm; 1999 May; 47(3):283-7. PubMed ID: 10382113
[TBL] [Abstract][Full Text] [Related]
3. Vehicle-dependent in situ modification of membrane-controlled drug release.
Imanidis G; Helbing-Strausak S; Imboden R; Leuenberger H
J Control Release; 1998 Jan; 51(1):23-34. PubMed ID: 9685901
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic analysis of pH-dependent solubility and trans-membrane permeability of amphoteric compounds: application to sildenafil.
Wang Y; Chow MS; Zuo Z
Int J Pharm; 2008 Mar; 352(1-2):217-24. PubMed ID: 18068319
[TBL] [Abstract][Full Text] [Related]
5. Calculation of skin permeability coefficient for ionized and unionized species of indomethacin.
Hayashi T; Sugibayashi K; Morimoto Y
Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3090-3. PubMed ID: 1477925
[TBL] [Abstract][Full Text] [Related]
6. Effect of Lipophilicity and Drug Ionization on Permeation Across Porcine Sublingual Mucosa.
Goswami T; Li X; Jasti BR
AAPS PharmSciTech; 2017 Jan; 18(1):175-181. PubMed ID: 26931443
[TBL] [Abstract][Full Text] [Related]
7. Cholic acids/salts as barriers to diffusing species: effect of pH.
Alhaique F; Memoli A; Santucci E
J Pharm Pharmacol; 1985 May; 37(5):336-7. PubMed ID: 2862242
[TBL] [Abstract][Full Text] [Related]
8. Transport of drugs across porous ion exchange membranes.
Akerman S; Viinikka P; Svarfvar B; Järvinen K; Kontturi K; Näsman J; Urtti A; Paronen P
J Control Release; 1998 Jan; 50(1-3):153-66. PubMed ID: 9685882
[TBL] [Abstract][Full Text] [Related]
9. Transport properties of ionic drugs in the ammonio methacrylate copolymer membranes.
Sun YM; Hsu SC; Lai JY
Pharm Res; 2001 Mar; 18(3):304-10. PubMed ID: 11442269
[TBL] [Abstract][Full Text] [Related]
10. In situ artificial membrane permeation assay under hydrodynamic control: permeability-pH profiles of warfarin and verapamil.
Velický M; Bradley DF; Tam KY; Dryfe RA
Pharm Res; 2010 Aug; 27(8):1644-58. PubMed ID: 20449764
[TBL] [Abstract][Full Text] [Related]
11. Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil.
Roy SD; Flynn GL
Pharm Res; 1990 Aug; 7(8):842-7. PubMed ID: 1978306
[TBL] [Abstract][Full Text] [Related]
12. How is Membrane Permeation of Small Ionizable Molecules Affected by Protonation Kinetics?
Harris J; Chipot C; Roux B
J Phys Chem B; 2024 Jan; 128(3):795-811. PubMed ID: 38227958
[TBL] [Abstract][Full Text] [Related]
13. Separation of drug traces from water with particular membrane systems.
Grote M; Haciosmanoglu B; Bataineh M; Nolte J
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2004; 39(4):1039-53. PubMed ID: 15137718
[TBL] [Abstract][Full Text] [Related]
14. Influence of pH on skin permeation of amino acids.
Hatanaka T; Kamon T; Uozumi C; Morigaki S; Aiba T; Katayama K; Koizumi T
J Pharm Pharmacol; 1996 Jul; 48(7):675-9. PubMed ID: 8866327
[TBL] [Abstract][Full Text] [Related]
15. Transbuccal delivery of acyclovir: I. In vitro determination of routes of buccal transport.
Shojaei AH; Berner B; Xiaoling L
Pharm Res; 1998 Aug; 15(8):1182-8. PubMed ID: 9706047
[TBL] [Abstract][Full Text] [Related]
16. Drug permeation through human skin II: Permeability of ionizable compounds.
Swarbrick J; Lee G; Brom J; Gensmantel NP
J Pharm Sci; 1984 Oct; 73(10):1352-5. PubMed ID: 6502479
[TBL] [Abstract][Full Text] [Related]
17. Ionisation effects on the permeation of pharmaceutical compounds through silicone membrane.
Waters LJ; Bhuiyan AKMMH
Colloids Surf B Biointerfaces; 2016 May; 141():553-557. PubMed ID: 26896663
[TBL] [Abstract][Full Text] [Related]
18. Development and characterization of mucoadhesive patches of salbutamol sulfate for unidirectional buccal drug delivery.
Puratchikody A; Prasanth VV; Mathew ST; Kumar BA
Acta Pharm; 2011 Jun; 61(2):157-70. PubMed ID: 21684844
[TBL] [Abstract][Full Text] [Related]
19. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration.
Salunke SR; Patil SB
Int J Biol Macromol; 2016 Jun; 87():41-7. PubMed ID: 26899173
[TBL] [Abstract][Full Text] [Related]
20. An extended model based on the modified Nernst-Planck equation for describing transdermal iontophoresis of weak electrolytes.
Imanidis G; Luetolf P
J Pharm Sci; 2006 Jul; 95(7):1434-47. PubMed ID: 16724334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
